These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33031122)

  • 1. Missed Opportunities Preceding Overdose Death: A Commentary on County Coroner's Overdose Data.
    Beauchamp GA; Grim SM; Minnich ED; Cannon RD; Land SD
    Am J Forensic Med Pathol; 2020 Dec; 41(4):342-343. PubMed ID: 33031122
    [No Abstract]   [Full Text] [Related]  

  • 2. [The message from heroin overdoses].
    Pap Á; Hegedűs K
    Orv Hetil; 2015 Mar; 156(9):352-7. PubMed ID: 25702255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fentanyl laced heroin and its contribution to a spike in heroin overdose in Miami-Dade County.
    Bode AD; Singh M; Andrews J; Kapur GB; Baez AA
    Am J Emerg Med; 2017 Sep; 35(9):1364-1365. PubMed ID: 28268113
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths.
    Parmar MK; Strang J; Choo L; Meade AM; Bird SM
    Addiction; 2017 Mar; 112(3):502-515. PubMed ID: 27776382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know.
    Kerensky T; Walley AY
    Addict Sci Clin Pract; 2017 Jan; 12(1):4. PubMed ID: 28061909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths.
    Rando J; Broering D; Olson JE; Marco C; Evans SB
    Am J Emerg Med; 2015 Sep; 33(9):1201-4. PubMed ID: 26095132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA.
    Bessen S; Metcalf SA; Saunders EC; Moore SK; Meier A; McLeman B; Walsh O; Marsch LA
    Int J Drug Policy; 2019 Dec; 74():144-151. PubMed ID: 31590090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use.
    Baltes A; Devo B; Kaiser M; Birstler J; Brown RT
    WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overdose Education and Naloxone Distribution in the San Francisco County Jail.
    Wenger LD; Showalter D; Lambdin B; Leiva D; Wheeler E; Davidson PJ; Coffin PO; Binswanger IA; Kral AH
    J Correct Health Care; 2019 Oct; 25(4):394-404. PubMed ID: 31672075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ensure global access to naloxone for opioid overdose management.
    Balster RL; Walsh SL
    Addiction; 2016 Apr; 111(4):589-90. PubMed ID: 26995171
    [No Abstract]   [Full Text] [Related]  

  • 11. Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention.
    Dietze P; Cantwell K
    Addiction; 2016 Apr; 111(4):584-6. PubMed ID: 26995168
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of COVID-19 Pandemic on Drug Overdoses in Indianapolis.
    Glober N; Mohler G; Huynh P; Arkins T; O'Donnell D; Carter J; Ray B
    J Urban Health; 2020 Dec; 97(6):802-807. PubMed ID: 33005988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does take-home naloxone reduce non-fatal overdose?
    Bennett T; Holloway K; Bird SM
    Lancet; 2014 Jan; 383(9912):124-5. PubMed ID: 24411967
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanding access to naloxone in the United States.
    Doyon S; Aks SE; Schaeffer S; ; ;
    Clin Toxicol (Phila); 2014 Dec; 52(10):989-92. PubMed ID: 25283253
    [No Abstract]   [Full Text] [Related]  

  • 15. Norway tries naloxone in spray form to prevent deaths from drug overdose.
    Hansen A
    BMJ; 2014 Feb; 348():g1686. PubMed ID: 24555965
    [No Abstract]   [Full Text] [Related]  

  • 16. Attitudes of Emergency Medical Service providers towards naloxone distribution programs.
    Tobin KE; Gaasch WR; Clarke C; MacKenzie E; Latkin CA
    J Urban Health; 2005 Jun; 82(2):296-302. PubMed ID: 15917504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.
    Langham S; Wright A; Kenworthy J; Grieve R; Dunlop WCN
    Value Health; 2018 Apr; 21(4):407-415. PubMed ID: 29680097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing the Fentanyl Threat to Public Health.
    Frank RG; Pollack HA
    N Engl J Med; 2017 Feb; 376(7):605-607. PubMed ID: 28199808
    [No Abstract]   [Full Text] [Related]  

  • 19. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
    Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
    J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency medicine services providers' attitudes toward naloxone distribution and training programs.
    Montoy JCC; Mercer MP; Silverman EC; Raven MC; LeSaint KT
    Am J Emerg Med; 2022 Jan; 51():76-78. PubMed ID: 34688204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.